Pharmacokinetics and Safety of Subcutaneous Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV-C) in Patients with Primary Immunodeficiency Disease (PID)

被引：1
|
作者：
Levy, R. [1 ]
Chen, J. [2 ]
Roberts, R. [3 ]
Sorrells, S. [2 ]
Stark, D. [4 ]
Tracy, J. [5 ]
Wasserman, R. L. [6 ]
Gupta, S. [7 ]
机构：
[1] Family Allergy & Asthma Ctr PC, Atlanta, GA USA
[2] Talecris Biotherapeut Inc, Res Triangle Pk, NC USA
[3] Univ Calif Los Angeles, Los Angeles, CA USA
[4] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[5] Allergy Asthma & Immunol Associates PC, Omaha, NE USA
[6] DallasAllergyImmunol, Dallas, TX USA
[7] Univ Calif Irvine, Irvine, CA USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2010年 / 125卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2009.12.549
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：AB140 / AB140
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics and safety of subcutaneous immune globulin (human), 10% caprylate/chromatography purified in patients with primary immunodeficiency disease
    Wasserman, R. L.
    Irani, A. -M.
    Tracy, J.
    Tsoukas, C.
    Stark, D.
    Levy, R.
    Chen, J.
    Sorrells, S.
    Roberts, R.
    Gupta, S.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2010, 161 (03): : 518 - 526
  • [2] Pharmacokinetics, Safety, and Tolerability of Subcutaneous Immune Globulin Injection (Human), 10 % Caprylate/Chromatography Purified (GAMUNEX®-C) in Pediatric Patients with Primary Immunodeficiency Disease
    Jennifer Heimall
    Junliang Chen
    Joseph A. Church
    Rhonda Griffin
    Isaac Melamed
    Gary I. Kleiner
    Journal of Clinical Immunology, 2016, 36 : 600 - 609
  • [3] Pharmacokinetics, Safety, and Tolerability of Subcutaneous Immune Globulin Injection (Human), 10 % Caprylate/Chromatography Purified (GAMUNEXA®-C) in Pediatric Patients with Primary Immunodeficiency Disease
    Heimall, Jennifer
    Chen, Junliang
    Church, Joseph A.
    Griffin, Rhonda
    Melamed, Isaac
    Kleiner, Gary I.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (06) : 600 - 609
  • [4] Timing of clinical response to immune globulin intravenous, 10% caprylate/chromatography purified (IGIV-C) in chronic inflammatory demyelinating polyneuropathy (CIDP)
    Latov, Norman
    Bril, Vera
    Dalakas, Marinos C.
    Deng, Chunqin
    Donofrio, Peter
    Hanna, Kim
    Hartung, Hans-Peter
    Hughes, Richard A. C.
    Merkies, Ingemar S. I.
    van Doorn, Pieter A.
    ANNALS OF NEUROLOGY, 2008, 64 : S8 - S8
  • [5] The ICE study: Immune globulin intravenous, 10% caprylate/chromatography purified (IGIV-C) for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) efficacy study
    Dalakas, Marinos
    Bril, Vera
    Donofrio, Peter
    Hartung, Hans-Peter
    Hughes, Richard
    Latov, Norman
    Merkies, Ingemar
    van Doorn, Pieter
    Deng, Chunqin
    Hanna, Kim
    Sommerauer, Bernd
    ANNALS OF NEUROLOGY, 2007, 62 : S69 - S69
  • [6] Quality-of-life (QoL) improvements with immune globulin intravenous, 10% caprylate/chromatography purified (IGIV-C) in chronic inflammatory demyelinating polyneuropathy (CIDP)
    Merkies, Ingemar S. J.
    Bril, Vera
    Dalakas, Marinos C.
    Deng, Chunquin
    Donofrio, Peter
    Hanna, Kim
    Hartung, Hans-Peter
    Hughes, Richard A. C.
    Latov, Norman
    van Doorn, Pieter A.
    ANNALS OF NEUROLOGY, 2008, 64 : S4 - S5
  • [7] Long-term safety profile of immune globulin intravenous, 10% caprylate/chromatography purified (IGIV-C; gamunex'®) therapy in the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP)
    Donofrio, Peter D.
    Bril, Vera
    Dalakas, Marinas
    Deng, Chunqin
    Hanna, Kim
    Hartung, Hans
    Hughes, Richard
    Latov, Norman
    Van Doorn, Pieter
    NEUROLOGY, 2008, 70 (11) : A367 - A367
  • [8] Long-term efficacy of immune globulin intravenous, 10% caprylate/chromatography purified (IGIV-C; Gamunex®) maintenance therapy for chronic inflammatory demyelinating polyneuropathy (CIDP)
    Donofrio, Peter
    Bril, Vera
    Dalakas, Marinos
    Deng, Chunqin
    Hanna, Kim
    Hartung, Hans
    Hughes, Richard
    Latov, Norman
    Merkies, Ingemar
    Van Doorn, Pieter
    NEUROLOGY, 2008, 70 (11) : A405 - A405
  • [9] Long-term safety profile (up to 48 weeks) of immune globulin intravenous, 10% caprylate/chromatography purified (IGIV-C; Gamunex®) therapy for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
    Hughes, R.
    Bril, V.
    Dalakas, M. C.
    Deng, C.
    Donofrio, P.
    Hanna, K.
    Hartung, H. P.
    Latov, N.
    Merkies, I.
    van Doorn, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 162 - 162
  • [10] Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency - A randomized double-blind trial
    Roifman, CM
    Schroeder, H
    Berger, M
    Sorensen, R
    Ballow, M
    Buckley, RH
    Gewurz, A
    Korenblat, P
    Sussman, G
    Lemm, G
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2003, 3 (09) : 1325 - 1333
12345